Your browser doesn't support javascript.
loading
Amelioration of mechanism-based inactivation of CYP3A4 by a H-PGDS inhibitor.
Vaz, Roy J; Li, Yi; Munson, Mark; Elliot, Michael; Thurairatnam, Sukanthini.
  • Vaz RJ; Integrated Drug Discovery, Sanofi US, 153-2nd Ave., Waltham, MA 02451, United States. Electronic address: roy.vaz@sanofi.com.
  • Li Y; Integrated Drug Discovery, Sanofi US, 153-2nd Ave., Waltham, MA 02451, United States.
  • Munson M; Integrated Drug Discovery, Sanofi US, 153-2nd Ave., Waltham, MA 02451, United States.
  • Elliot M; Drug Metabolism & PK, Sanofi US, 153-2nd Ave., Waltham, MA 02451, United States.
  • Thurairatnam S; Integrated Drug Discovery, Sanofi US, 153-2nd Ave., Waltham, MA 02451, United States.
Bioorg Med Chem Lett ; 28(18): 3046-3049, 2018 10 01.
Article en En | MEDLINE | ID: mdl-30115511
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sulfonamidas / Citocromo P-450 CYP3A / Inhibidores del Citocromo P-450 CYP3A / Indoles Límite: Humans Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sulfonamidas / Citocromo P-450 CYP3A / Inhibidores del Citocromo P-450 CYP3A / Indoles Límite: Humans Idioma: En Año: 2018 Tipo del documento: Article